ABEO Abeona Therapeutics
- 4.0850
- +0.6450+18.75%
Abeona Therapeutics News
Abeona Therapeutics(ABEO.US) Director Buys US$24,764 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Director Charles Faith L. purchased 7,550 shares of common stock on Apr 26, 2024 at an average price of $3.28 for a total value of $24,764.Source: Announcement What is s
Abeona Therapeutics(ABEO.US) Officer Buys US$32,000 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Officer Seshadri Vishwas purchased 10,000 shares of common stock on Apr 25, 2024 at an average price of $3.2 for a total value of $32,000.Source: Announcement What is st
Abeona Therapeutics(ABEO.US) Officer Buys US$17,609.12 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Officer Vazzano Joseph Walter purchased 5,608 shares of common stock on Apr 25, 2024 at an average price of $3.14 for a total value of $17,609.12.Source: Announcement Wh
Abeona Therapeutics(ABEO.US) Officer Buys US$27,864 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Officer O'Malley Brendan M. purchased 8,600 shares of common stock on Apr 25, 2024 at an average price of $3.24 for a total value of $27,864.Source: Announcement What is
Abeona Therapeutics: Key Director Elections and Share Resolutions Passed
Insider Buyers Lose Additional US$35k As Abeona Therapeutics Dips To US$93m
The recent 57% drop in Abeona Therapeutics Inc.'s (NASDAQ:ABEO) stock could come as a blow to insiders who purchased US$192.1k worth of stock at an average buy price of US$4.18 over the past 12 months
Express News | Abeona Therapeutics Inc : Jefferies Cuts Target Price to $14 From $16
Sector Update: Health Care Stocks Rise Late Afternoon
Health care stocks gained late Tuesday afternoon, with the NYSE Health Care Index climbing 1.3% and the Health Care Select Sector SPDR Fund (XLV) adding 1.2%. The iShares Biotechnology ETF (IBB) climb
Top Midday Decliners
Abeona Therapeutics (ABEO) shares sank nearly 54% amid heavy trading after the company said late Monday that it plans to resubmit its biologic license application for pz-cel after the US Food and Drug
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
KOPN, BTCM and CETX Among Mid-day Movers
Dow Jumps Over 200 Points; US Services PMI Falls In April
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Tuesday.The Dow traded up 0.60% to 38,470.94 while the NASDAQ rose 1.44% to 15,673.22. The S&P 500
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience Among Healthcare Movers
FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink
On Monday, Abeona Therapeutics Inc (NASDAQ:ABEO) announced a regulatory update for prademagene zamikeracel (pz-cel). The FDA has issued a Complete Response Letter (CRL) in response to the company's Bi
Express News | Cantor Fitzgerald Reiterates Overweight on Abeona Therapeutics, Maintains $36 Price Target
Abeona Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/23/2024 797.76% Cantor Fitzgerald → $36 Reiterates Overweight → Overweight 08/24/2023 847.63% Cantor Fi
Market-Moving News for April 23rd
ABEO: -55% | Abeona Therapeutics shares are trading lower after the company announced the FDA issued a Complete Response Letter in response to the company's Biologics License Application for pz-cel fo
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. The company's market cap stands at $4.4 billion. Nuwellis (NASDAQ:NUWE) shares increased by
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transactio
Top Premarket Decliners
Abeona Therapeutics (ABEO) shares slumped 48% Tuesday premarket after the company said that it plans to resubmit its biologic license application for pz-cel after the US Food and Drug Administration h
Analysis
Price Target
No Data
